5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18363435 | ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF | SULLIVAN, DENNIS JOHN | 1642 | Final Rejection | Aug 01, 2023 |
| 18193979 | TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOF | LI, RUIXIANG | 1674 | Final Rejection | Mar 31, 2023 |
| 17791859 | TGFB INHIBITORS AND USE THEREOF | DUFFY, PATRICIA ANN | 1645 | Non-Final OA | Jul 08, 2022 |
| 17758524 | TGF-BETA INHIBITORS AND USE THEREOF | O'BRIEN, LEA S | 1646 | Non-Final OA | Jul 08, 2022 |
| 17248700 | USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES | SULLIVAN, STEPHANIE LAUREN | 1635 | Non-Final OA | Feb 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial